(Finance) – Il Dr. Max Groupone of the most important networks specialized in pharmacy management in Europe, has purchased the Italian chain Neo Apotekin a strategic move that brings the total number of Dr. Max pharmacies at over 210 in Italy. In particular, the addition of over 130 pharmacies further strengthens Dr. Max’s presence in the area, with a significant impact in both tourist locations and metropolitan cities, in particular Milan, Venice, Verona, Bergamo and Turin.
“With the acquisition of Neo Apotek, we consolidate our commitment to a path of rapid development in Italy, a path that began with the opening of the first Dr. Max pharmacy in 2018 – he stated Leonardo FerrandinoCEO of the Dr. Max Group – Our vision is clear: Dr. Max is already the market leader in numerous European countries and we are determined to achieve a leadership position in Italy too.”
Dr. Max’s rapid growth over the past year has included the acquisition of more than 35 pharmacies in various Italian cities, as well as continued investment in staff and stores across the country. Dr. Max, which is controlled by Penta Investments, has been present on the European market since 2014 and with over 3,000 physical and online points of sale.
“This operation marks a historic moment for the company and for our sector in Italy – he commented Alessandro UrbaniCEO of Dr. Max Italia – With this acquisition, we have increased the number of Dr. Max employees to over 1,300, including pharmacists and industry professionals, demonstrating the solidity of our development plan in the country and the great capacity of the Dr. team. Max to make it happen.”